McKesson hid security flaws that fueled opioid epidemic, the lawsuit alleges – by ALEX KACIK
McKesson Corp. allegedly concealed security flaws in its supply chain, which fueled the opioid epidemic, according to a recently unsealed whistleblower case.
Former employees at the wholesale drug distribution giant claim that McKesson would hide the extent of its security issues from the federal government and falsely represented that it would comply with two settlement agreements. Millions of the addictive pain pills were diverted to the black market as a result, according to the lawsuit.
This is the source of all the opioid medications that flooded the black market. (I’ve been pointing this out for years.) Continue reading
Nonopioid Overdose Death Rates Rose Almost As Fast As Those Involving Opioids, 1999-2016. – PubMed – NCBI – Jul 2019
Even 6 months ago, it was becoming clear that overdoses aren’t “caused by opioids”, but rather all kinds of drugs, of which illicit opioids like fentanyl undoubtedly play a huge part.
But they are still trying to link all the overdoses to opioids using the most inside-out reasoning (if it can even be called that) that’s clearly influenced by PROPaganda.
The number of Americans dying from drug overdoses has risen rapidly, but the contribution of nonopioid drugs to this growth is not well understood.
And it won’t be understood until they clear their heads of the nonsense they’ve been flooded with. Continue reading
Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study – Nov 2019
I’m not going to pretend to be impartial and scientific anymore – this obscene charade of drug-warriors fighting what they call an “opioid epidemic” has gone to such ridiculous extremes (no opioids after cutting open a woman’s abdomen to pull her baby out) that I can no longer restrain my outrage.
With governments’ increasing efforts to curb opioid prescription use and limit dose below the Centers for Disease Control and Prevention (CDC)-recommended threshold of 90 morphine milligram equivalents per day, little is known about prescription opioid patterns preceding opioid use disorder (OUD) or overdose.
Limiting opioid prescriptions never worked in the past, isn’t working now, and never will work. It cannot work because legitimate opioid prescriptions are not related to opioid overdoses. How long will it take these bureaucrats to figure this out? Continue reading
AI-based product aims to help providers identify missed charges | Health Data Management – By Joseph Goedert – Sep 2019
It’s always interesting to look at a subject from a different point of view because it gives a more complete picture. I found this article in a publication called “Health Data Management”, which is focused on the health data and computing aspect of healthcare and has nothing to do with medical care.
This article predictably uses the generic functional term “provider” for doctors and nurses, a standardized and interchangeable version of the real people actually practicing medicine.
This is a hint of what we can expect in the future of healthcare after AI systems are embedded in every facet of our care: standardized “providers” will follow standard algorithms to diagnose and treat “standard” patients, who are all assumed to be the mythical “average human”. Continue reading
How Did We Come to Abandon America’s Pain Patients? – Filter Magazine – Alison Knopf – July 2019
Overdoses—not those involving prescription opioids, but of heroin and illicit fentanyl, often combined with benzodiazepines—continue to go up. But
And many physicians, caught in the middle, have stopped prescribing because they don’t want to get in trouble and possibly lose their livelihood. Continue reading
Diagnosis Codes Index – Opioid related disorders (F11)
In the new ICD-10 system for medical billing codes, there’s a specific code for anything and everything to do with opioids. There’s even a code for “opioid use, unspecified, uncomplicated“, which seems to indicate that any “use” of opioids is a medical problem in itself.
We can see how “the medical system” is organized by looking at how healthcare services are billed. Looking at the hierarchy of categories in this billing scheme, we can discover how they see us, pain patients, using opioids.
The problems start at the top level: our “code” is listed under the category of “Mental disorders”:
Mental and behavioural disorders (F00–F99) Continue reading
‘Business decision’: Former DEA official works for opioid lawyers but set standards for how many pills were made – By John O’Brien | Sep 3, 2019
The DEA knew more about what quantities of opioids went where than anyone else, so I’m baffled why they didn’t stop the excessive orders that everyone is complaining about now.
Asked what would’ve happened if a pharmaceutical distributor wanted advice on whether a large order of opioids was suspicious, the man in charge of federal regulation of those pills for 10 years said he wouldn’t have helped.
Instead, Joe Rannazzisi, who set always-increasing opioid quotas for theindustry while he headed a Drug Enforcement Agency department from 2005-15, said the company would be left on its own to figure it out. Continue reading
Health-Care CEOs Made an Infuriating Amount of Money Last Year – by Luke Darby – Apr 2019
While I know that CEOs are ridiculously overpaid these days, I’m disgusted by the amount of money, much of it from taxpayers, that’s sloshing around in the healthcare industry.
Last year, 62 CEOs of health-care companies made a combined total of $1.1 billion in compensation.
That’s according to a new report out from Axios, which coincidentally notes that CEO compensation eclipses what the Centers for Disease Control spent on chronic disease prevention by $157 million. Continue reading
Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study. – Pub Med – J Gen Intern Med. – Aug 2019
This study exposes the horrific aftermath of forced opioid tapers when patients are expelled from medical care because doctors have a reasonable fear of losing their livelihoods if treating pain with opioids.
Opioid tapering is increasingly utilized by providers to decrease risks of chronic opioid therapy, but it is unknown whether tapering is associated with termination of care.
Addiction Is Not Dependence – practicalpainmanagement.com – Aug 2019
In this editorial, Jennifer P. Schneider, MD, PhD, digs into a common—and frustrating—misunderstanding in pain medicine terminology.
FDA approved the buprenorphine implant, branded as Probuphine, in 2016 “for the maintenance treatment of opioid dependence.”
- Was it approved for the treatment of what we now call Opioid Use Disorder (OUD)?
- Or was the intent to approve it for physical dependence, a condition found in most opioid-treated chronic pain patients as well as opioid addicts?
It is not clear from the language. Continue reading